Effect of pulse width variations on sacral neuromodulation for overactive bladder symptoms: A prospective randomized crossover feasibility study

Abstract

AbstractIntroduction/BackgroundThe pulse width (PW) parameter in sacral neuromodulation (SNM) is understudied, with no evidence‐based guidance available on optimal PW for urinary indications. The aim of this prospective, randomized, single‐blinded, 3 × 3 cross over design study was to estimate the effect of two PW settings (60 µs, 420 µs) compared to the industry standard (210 µs) on SNM efficacy, quality of life, and device parameters in patients who were stable and satisfied with their SNM treatment.Methods/MaterialsEligible patients were previously implanted and had urge incontinence or urgency‐frequency with satisfaction on SNM at time of enrollment. Patients completed a 3‐day voiding diary, validated questionnaires, and device interrogations with sensory threshold assessment at baseline and after a 4‐week period on each of the three PW settings, to which they were randomized. Eighteen participants completed the study, as called for by power analysis.ResultsEighteen patients were enrolled in the study. Mean age was 68 years and implant duration at the time of participation was 4.4 years. While PW variations did not produce significant differences in overall objective outcomes, device parameters, including sensory threshold amplitude and battery life differed significantly. Shortened PW necessitated higher amplitude while conserving battery life. Stimulus sensation location, quality, and intensity did not differ between PW. Standard PW was chosen by 11 patients after the study, 5 chose extended, and 2 chose shortened. Those who chose alternative PW achieved significant reductions in urinary frequency from enrollment −2.23 voids/day (p = 0.015). Upon sub‐analysis, patients reporting “much better” or “very much better” on extended PW achieved significant reductions in urinary frequency and nocturia at 5.6 and 0.4, compared to 8.5 and 2.16 at baseline (p = 0.005, p = <0.001). Whereas those reporting “much better” or “very much better” on shortened PW achieved significant reductions in urinary frequency at 5.15 compared to 7.35 (p = 0.026). There were no adverse events or complications.ConclusionsOverall SNM effectiveness was unchanged with alternative PW; however, 39% of patients preferred alternative to standard PW and achieved significant improvements in urinary symptoms with such. Shorter PW can also provide savings in estimated battery life without sacrificing therapeutic efficacy.